236 related articles for article (PubMed ID: 25156972)
1. Immunomodulators to treat recurrent miscarriage.
Prins JR; Kieffer TE; Scherjon SA
Eur J Obstet Gynecol Reprod Biol; 2014 Oct; 181():334-7. PubMed ID: 25156972
[TBL] [Abstract][Full Text] [Related]
2. What is wrong with the regulatory T cells and foetomaternal tolerance in women with recurrent miscarriages?
Craenmehr MH; Heidt S; Eikmans M; Claas FH
HLA; 2016 Feb; 87(2):69-78. PubMed ID: 26841054
[TBL] [Abstract][Full Text] [Related]
3. The basis and value of currently used immunomodulatory therapies in recurrent miscarriage.
Bansal AS; Bajardeen B; Thum MY
J Reprod Immunol; 2012 Jan; 93(1):41-51. PubMed ID: 22196105
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the expression of Th17 cells and regulatory T cells by IL-27 in patients with unexplained early recurrent miscarriage.
Wang WJ; Liu FJ; Qu HM; Hao CF; Qu QL; Xiong-Wang ; Bao HC; Wang XR
J Reprod Immunol; 2013 Sep; 99(1-2):39-45. PubMed ID: 23731956
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of human chorionic gonadotrophin-mediated immunomodulation in pregnancy.
Bansal AS; Bora SA; Saso S; Smith JR; Johnson MR; Thum MY
Expert Rev Clin Immunol; 2012 Nov; 8(8):747-53. PubMed ID: 23167686
[TBL] [Abstract][Full Text] [Related]
6. The role of dydrogesterone in recurrent (habitual) abortion.
Gruber CJ; Huber JC
J Steroid Biochem Mol Biol; 2005 Dec; 97(5):426-30. PubMed ID: 16188436
[TBL] [Abstract][Full Text] [Related]
7. Experience in IVIg therapy for selected women with recurrent reproductive failure and NK cell expansion.
Ramos-Medina R; García-Segovia A; Gil J; Carbone J; Aguarón de la Cruz A; Seyfferth A; Alonso B; Alonso J; León JA; Alecsandru D; Meliá E; Carrillo de Albornoz E; Ordoñez D; Santillán I; Verdú V; Garcia Ruiz de Morales JM; López-Hoyos M; López Larios A; Sampalo A; Caballero P; Ortiz Quintana L; Fernández-Cruz E; Sánchez-Ramón S
Am J Reprod Immunol; 2014 May; 71(5):458-66. PubMed ID: 24612159
[TBL] [Abstract][Full Text] [Related]
8. Cytokine imbalance at materno-embryonic interface as a potential immune mechanism for recurrent pregnancy loss.
Ali S; Majid S; Ali MN; Taing S; Rehman MU; Arafah A
Int Immunopharmacol; 2021 Jan; 90():107118. PubMed ID: 33191177
[TBL] [Abstract][Full Text] [Related]
9. Regulatory T cells, maternal-foetal immune tolerance and recurrent miscarriage: new therapeutic challenging opportunities.
Alijotas-Reig J; Melnychuk T; Gris JM
Med Clin (Barc); 2015 Mar; 144(6):265-8. PubMed ID: 24667109
[TBL] [Abstract][Full Text] [Related]
10. Immune profiling in patients with recurrent miscarriage.
Kuon RJ; Strowitzki T; Sohn C; Daniel V; Toth B
J Reprod Immunol; 2015 Apr; 108():136-41. PubMed ID: 25771397
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-6 in pregnancy and gestational disorders.
Prins JR; Gomez-Lopez N; Robertson SA
J Reprod Immunol; 2012 Sep; 95(1-2):1-14. PubMed ID: 22819759
[TBL] [Abstract][Full Text] [Related]
12. Recurrent miscarriage: causes, evaluation and management.
Garrido-Gimenez C; Alijotas-Reig J
Postgrad Med J; 2015 Mar; 91(1073):151-62. PubMed ID: 25681385
[TBL] [Abstract][Full Text] [Related]
13. [The management of unexplained recurrent abortions. Is immunotherapy an option?].
Constantinescu D; Cozmei C; Dumitraşcu I; Carasevici E
Rev Med Chir Soc Med Nat Iasi; 2008; 112(2):371-8. PubMed ID: 19295006
[TBL] [Abstract][Full Text] [Related]
14. Unexplained Recurrent Miscarriage and Recurrent Implantation Failure: Is There a Place for Immunomodulation?
Mekinian A; Cohen J; Alijotas-Reig J; Carbillon L; Nicaise-Roland P; Kayem G; Daraï E; Fain O; Bornes M
Am J Reprod Immunol; 2016 Jul; 76(1):8-28. PubMed ID: 26847715
[TBL] [Abstract][Full Text] [Related]
15. Th17 and regulatory T cells in women with recurrent pregnancy loss.
Lee SK; Kim JY; Lee M; Gilman-Sachs A; Kwak-Kim J
Am J Reprod Immunol; 2012 Apr; 67(4):311-8. PubMed ID: 22380579
[TBL] [Abstract][Full Text] [Related]
16. Oral sex is associated with reduced incidence of recurrent miscarriage.
Meuleman T; Baden N; Haasnoot GW; Wagner MM; Dekkers OM; le Cessie S; Picavet C; van Lith JMM; Claas FHJ; Bloemenkamp KWM
J Reprod Immunol; 2019 Jun; 133():1-6. PubMed ID: 30980918
[TBL] [Abstract][Full Text] [Related]
17. Intravenous immunoglobulin G modulates peripheral blood Th17 and Foxp3(+) regulatory T cells in pregnant women with recurrent pregnancy loss.
Kim DJ; Lee SK; Kim JY; Na BJ; Hur SE; Lee M; Kwak-Kim J
Am J Reprod Immunol; 2014 May; 71(5):441-50. PubMed ID: 24645850
[TBL] [Abstract][Full Text] [Related]
18. The Impact of New Immunological Therapeutic Strategies on Recurrent Miscarriage and Recurrent Implantation Failure.
Parhizkar F; Motavalli-Khiavi R; Aghebati-Maleki L; Parhizkar Z; Pourakbari R; Kafil HS; Danaii S; Yousefi M
Immunol Lett; 2021 Aug; 236():20-30. PubMed ID: 34090942
[TBL] [Abstract][Full Text] [Related]
19. Recurrent miscarriage.
Katz VL; Kuller JA
Am J Perinatol; 1994 Nov; 11(6):386-97. PubMed ID: 7857427
[TBL] [Abstract][Full Text] [Related]
20. Recurrent miscarriage.
Rai R; Regan L
Lancet; 2006 Aug; 368(9535):601-11. PubMed ID: 16905025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
